These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 29530207)

  • 21. Acute coronary syndrome registry enrolment status: differences in patient characteristics and outcomes and implications for registry data use (ANZACS-QI 36).
    Earle NJ; Kerr AJ; Legget M; Wu BP; Doughty RN; Poppe KK
    Eur Heart J Qual Care Clin Outcomes; 2021 Oct; 7(6):542-547. PubMed ID: 31393578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Economic Evaluation of the All New Zealand Acute Coronary Syndrome Quality Improvement Registry Program (ANZACS-QI 28).
    Lee P; Zomer E; Liew D
    Heart Lung Circ; 2020 Jul; 29(7):1046-1053. PubMed ID: 31537440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An economic evaluation of the All New Zealand Acute Coronary Syndrome Quality Improvement Registry programme-subanalyses for Māori (ANZACS-QI 42).
    Lee P; Zomer E; Liew D
    N Z Med J; 2020 May; 133(1514):16-32. PubMed ID: 32379736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
    Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
    Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use and misuse of statins after ACS: analysis of a prescription database of a community setting of 2,042,968 subjects.
    Maggioni AP; Rossi E; Cinconze E; De Rosa M;
    Eur J Prev Cardiol; 2014 Sep; 21(9):1109-16. PubMed ID: 23539716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A nurse-led and medically supported outpatient follow-up model following an acute coronary syndrome is as safe and effective as medical follow-up alone (ANZACS-QI 69).
    McLachlan A; Kerr A; Lee M
    N Z Med J; 2022 Oct; 135(1563):12-28. PubMed ID: 36201727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence-based prescribing of drugs for secondary prevention of acute coronary syndrome in Aboriginal and non-Aboriginal patients admitted to Western Australian hospitals.
    Gausia K; Katzenellenbogen JM; Sanfilippo FM; Knuiman MW; Thompson PL; Hobbs MS; Thompson SC
    Intern Med J; 2014 Apr; 44(4):353-61. PubMed ID: 24528930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study.
    Ye X; Gross CR; Schommer J; Cline R; St Peter WL
    Clin Ther; 2007 Dec; 29(12):2748-57. PubMed ID: 18201593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of removing funding restrictions for atorvastatin differed across sociodemographic groups among New Zealanders hospitalised with cardiovascular disease: a national data linkage study.
    Mehta S; Wells S; Jackson R; Harrison J; Kerr A
    N Z Med J; 2016 Oct; 129(1443):18-29. PubMed ID: 27736849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromes.
    Gencer B; Rodondi N; Auer R; Räber L; Klingenberg R; Nanchen D; Carballo D; Vogt P; Carballo S; Meyer P; Matter CM; Windecker S; Lüscher TF; Mach F
    Eur J Intern Med; 2015 Jan; 26(1):56-62. PubMed ID: 25582072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. National variation in coronary angiography rates and timing after an acute coronary syndrome in New Zealand (ANZACS-QI 6).
    Williams MJ; Harding SA; Devlin G; Nunn C; El-Jack S; Scott T; Lee M; Kerr AJ;
    N Z Med J; 2016 Jan; 129(1428):66-78. PubMed ID: 26914194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic aspirin and statin therapy in patients with impaired renal function and acute coronary syndromes: results from the IN-ACS Outcome Registry.
    Sciahbasi A; Rizzello V; Gonzini L; Giampaoli S; Greco C; Di Pasquale G; Mureddu GF; Di Chiara A; Lioy E; Boccanelli A
    Eur J Prev Cardiol; 2014 Feb; 21(2):214-21. PubMed ID: 22952286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of evidence-based therapy for the secondary prevention of acute coronary syndromes in Malaysian practice.
    Kassab YW; Hassan Y; Aziz NA; Akram H; Ismail O
    J Eval Clin Pract; 2013 Aug; 19(4):658-63. PubMed ID: 22845427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of 1-year outcomes in the Taiwan Acute Coronary Syndrome Full Spectrum Registry.
    Chiang FT; Shyu KG; Wu CJ; Mar GY; Hou CJ; Li AH; Wen MS; Lai WT; Lin SJ; Kuo CT; Kuo C; Li YH; Hwang JJ;
    J Formos Med Assoc; 2014 Nov; 113(11):794-802. PubMed ID: 24076272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-reported use of evidence-based medicine and smoking cessation 6 - 9 months after acute coronary syndrome: a single-centre perspective.
    Griffiths B; Lesosky M; Ntsekhe M
    S Afr Med J; 2014 Jun; 104(7):483-7. PubMed ID: 25214049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl.
    Spencer FA; Goldberg RJ; Gore JM; Fox KA; Avezum A; Agnelli G; Kritharides L; Anderson FA; Goodman SG; FitzGerald G; Allegrone J; Brieger D;
    Am J Cardiol; 2007 Sep; 100(6):913-8. PubMed ID: 17826369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using the general practice EMR for improving blood pressure medication adherence.
    Warren J; Kennelly J; Warren D; Elley CR; Wai KC; Manukia M; Davy J; Mabotuwana T; Robinson E
    Stud Health Technol Inform; 2012; 178():228-34. PubMed ID: 22797046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of statin prescription in acute myocardial infarction: the French registry of Acute ST-elevation or non-ST-elevation Myocardial Infarction (FAST-MI).
    Ferrières J; Bataille V; Leclercq F; Geslin P; Ruidavets JB; Grollier G; Bernard P; Cambou JP; Simon T; Danchin N
    Atherosclerosis; 2009 Jun; 204(2):491-6. PubMed ID: 19004441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines on the prescription of high-intensity statins in patients hospitalized for acute coronary syndrome or stroke.
    Valentino M; Al Danaf J; Panakos A; Ragupathi L; Duffy D; Whellan D
    Am Heart J; 2016 Nov; 181():130-136. PubMed ID: 27823684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.